Literature DB >> 29380181

Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall.

Taro Mohri1,2, Yoshihiro Ikura3, Asako Hirakoso1,2, Masashi Okamoto4, Masakatsu Hishizawa5, Akifumi Takaori-Kondo5, Seiichi Kato6,7, Shigeo Nakamura6, Kai Yoshimura1, Hidetoshi Okabe1, Yasuhiro Iwai1.   

Abstract

We report a case of classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder (HL-PTLD) after kidney transplantation to highlight the difficulty of distinguishing this disorder from Hodgkin lymphoma-like PTLD (HL-like PTLD). Through this case report and literature review, we seek to clarify definitive pathologic features to differentiate these two conditions. A 38-year-old male kidney transplant recipient who had been receiving immunosuppressants was admitted to our hospital with unidentified high fever. Computed tomography images and blood tests indicated a lymphoproliferative disorder. Abdominal lymph node biopsy was performed, and microscopic examination revealed the presence of many large atypical cells in a background of dense T cell accumulation. The large, atypical cells were positive for Epstein-Barr Virus (EBV)-encoded small RNAs (EBER) in situ hybridization, EBV-LMP1, CD30 and PAX5, but negative for CD15, CD20 and CD45. Except for CD15-negativity, this immunohistochemical pattern was consistent with that of classical Hodgkin lymphoma. By close examination of the above immunoreactivities and the patient's subsequent chemosensitive clinical course, we finally made a diagnosis of HL-PTLD.

Entities:  

Keywords:  Classical Hodgkin lymphoma; Immunohistochemistry; Post-transplant lymphoproliferative disorder

Mesh:

Substances:

Year:  2018        PMID: 29380181     DOI: 10.1007/s12185-018-2410-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

1.  Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.

Authors:  Sean D Pitman; Qin Huang; Craig W Zuppan; Edward H Rowsell; Jeffrey D Cao; Jesus G Berdeja; Lawrence M Weiss; Jun Wang
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

Review 2.  Epstein-Barr virus and renal transplantation.

Authors:  Jade Le; Christine M Durand; Irfan Agha; Daniel C Brennan
Journal:  Transplant Rev (Orlando)       Date:  2016-12-29       Impact factor: 3.943

3.  Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.

Authors:  Sabrina Basso; Marco Zecca; Lucia Calafiore; Laura Rubert; Roberto Fiocchi; Marco Paulli; Giuseppe Quartuccio; Ilaria Guido; Roberta Sebastiani; Giorgio Alberto Croci; Claudia Beschi; Ida Nardiello; Fabrizio Ginevri; Chiara Cugno; Patrizia Comoli
Journal:  Pediatr Transplant       Date:  2013-09-01

4.  Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature.

Authors:  Gabriela Gheorghe; Edythe A Albano; Christopher C Porter; Loris McGavran; Qi Wei; Lynne Meltesen; Susan M Danielson; Xiayuan Liang
Journal:  J Pediatr Hematol Oncol       Date:  2007-02       Impact factor: 1.289

5.  A 47-year-old stem cell transplant recipient with fever, cough and chest pain.

Authors:  Omar S Salh; Omar N Nadhem; Sanket R Thakore; Ruba A Halloush; Faisal A Khasawneh
Journal:  Can Respir J       Date:  2015 May-Jun       Impact factor: 2.409

Review 6.  Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis.

Authors:  Yanxia Jiang; Yan Chen; Ruibin Huang; Guoan Chen
Journal:  Int J Hematol       Date:  2016-08-16       Impact factor: 2.490

7.  Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.

Authors:  Toshinari Yagi; Jun Ishikawa; Nana Aono; Yukiko Yamashita; Shinsuke Kusakabe; Tetsuhiro Yoshinami; Yuki Akazawa; Daisuke Sakai; Sachiko Yamamoto; Yuri Hamanaka; Hiroaki Masaie; Naotoshi Sugimoto; Hitoshi Yoshida; Yasuhiko Tomita; Fumio Imamura
Journal:  Int J Hematol       Date:  2011-12-16       Impact factor: 2.490

8.  Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms.

Authors:  Heiner Adams; Peter Liebisch; Patrik Schmid; Stephan Dirnhofer; Alexandar Tzankov
Journal:  Appl Immunohistochem Mol Morphol       Date:  2009-03

9.  Is an increase in CD4/CD8 T-cell ratio in lymph node fine needle aspiration helpful for diagnosing Hodgkin lymphoma? A study of 85 lymph node FNAs with increased CD4/CD8 ratio.

Authors:  Osvaldo Hernandez; Thaira Oweity; Sherif Ibrahim
Journal:  Cytojournal       Date:  2005-09-09       Impact factor: 2.091

10.  Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma.

Authors:  Alberto Zambelli; Daniele Lilleri; Fausto Baldanti; Mario Scelsi; Laura Villani; Gian Antonio Da Prada
Journal:  BMC Cancer       Date:  2005-08-23       Impact factor: 4.430

View more
  1 in total

1.  Epstein-Barr virus-positive post-transplant lymphoproliferative disordepresenting as hematochezia and enterobrosis in renal transplant recipients in China: A report of two cases.

Authors:  Ze-Jia Sun; Xiao-Peng Hu; Bo-Han Fan; Wei Wang
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.